{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:34:12Z","timestamp":1792056852070,"version":"4.4.0"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR001412"],"award-info":[{"award-number":["UL1TR001412"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000052","name":"National Institutes of Health Office of the Director","doi-asserted-by":"publisher","award":["OD025204"],"award-info":[{"award-number":["OD025204"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007159","name":"Western Michigan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007159","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["R01DE29472"],"award-info":[{"award-number":["R01DE29472"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jaut.2025.103467","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T03:38:10Z","timestamp":1753846690000},"page":"103467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Tlr9 expression protects against Tlr7-dependent exocrine gland and systemic disease manifestations in primary Sj\u00f6gren's disease in a sex-biased manner"],"prefix":"10.1016","volume":"156","author":[{"given":"Sheta","family":"Biswas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen M.","family":"Kasperek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengsong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey C.","family":"Miecznikowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Osinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose-Anne","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9828-8556","authenticated-orcid":false,"given":"Jill M.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jaut.2025.103467_bib1","first-page":"97","article-title":"Primary Sjogren's syndrome","volume":"379","author":"Mariette","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.jaut.2025.103467_bib2","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/acr.23223","article-title":"Primary Sjogren's Syndrome Prevalence: What if Sjogren was Right After All? Comment on the Article by Maciel et al","volume":"70","author":"Nocturne","year":"2018","journal-title":"Arthritis Care Res."},{"issue":"1","key":"10.1016\/j.jaut.2025.103467_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10238-021-00728-6","article-title":"Sjogren's syndrome: a systemic autoimmune disease","volume":"22","author":"Negrini","year":"2022","journal-title":"Clin. Exp. Med."},{"issue":"1","key":"10.1016\/j.jaut.2025.103467_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/art.23177","article-title":"Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I","volume":"58","author":"Helmick","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.jaut.2025.103467_bib5","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.2174\/138920112802273100","article-title":"B-lymphocytes govern the pathogenesis of Sjogren's syndrome","volume":"13","author":"Youinou","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"2","key":"10.1016\/j.jaut.2025.103467_bib6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1097-2765(00)80136-7","article-title":"MyD88 is an adaptor protein in the hToll\/IL-1 receptor family signaling pathways","volume":"2","author":"Medzhitov","year":"1998","journal-title":"Mol Cell"},{"key":"10.1016\/j.jaut.2025.103467_bib7","article-title":"Toll-like receptors gene polymorphisms in autoimmune disease","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.jaut.2025.103467_bib8","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1002\/art.22571","article-title":"Protection against autoimmune nephritis in MyD88-deficient MRL\/lpr mice","volume":"56","author":"Sadanaga","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.jaut.2025.103467_bib9","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.4049\/jimmunol.0902592","article-title":"TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus","volume":"184","author":"Nickerson","year":"2010","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.jaut.2025.103467_bib10","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.immuni.2012.11.017","article-title":"Signals via the adaptor MyD88 in B cells and DCs make distinct and synergistic contributions to immune activation and tissue damage in lupus","volume":"38","author":"Teichmann","year":"2013","journal-title":"Immunity"},{"issue":"6881","key":"10.1016\/j.jaut.2025.103467_bib11","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/416603a","article-title":"Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors","volume":"416","author":"Leadbetter","year":"2002","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jaut.2025.103467_bib12","doi-asserted-by":"crossref","first-page":"875","DOI":"10.4049\/jimmunol.1300683","article-title":"Requirement for MyD88 signaling in B cells and dendritic cells for germinal center anti-nuclear antibody production in Lyn-deficient mice","volume":"192","author":"Hua","year":"2014","journal-title":"J. Immunol."},{"issue":"35","key":"10.1016\/j.jaut.2025.103467_bib13","doi-asserted-by":"crossref","first-page":"E3311","DOI":"10.1073\/pnas.1300617110","article-title":"Hyperactivated MyD88 signaling in dendritic cells, through specific deletion of Lyn kinase, causes severe autoimmunity and inflammation","volume":"110","author":"Lamagna","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.jaut.2025.103467_bib14","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3899\/jrheum.2022-0827","article-title":"Type I interferons in autoimmunity: implications in clinical phenotypes and treatment response","volume":"50","author":"Londe","year":"2023","journal-title":"J. Rheumatol."},{"issue":"13","key":"10.1016\/j.jaut.2025.103467_bib15","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1084\/jem.20080462","article-title":"TLR7-dependent and FcgammaR-independent production of type I interferon in experimental mouse lupus","volume":"205","author":"Lee","year":"2008","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.jaut.2025.103467_bib16","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1189\/jlb.3A0717-311R","article-title":"Myd88 is required for disease development in a primary Sjogren's syndrome mouse model","volume":"102","author":"Kiripolsky","year":"2017","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jaut.2025.103467_bib17","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.3389\/fimmu.2019.02963","article-title":"Activation of myd88-dependent TLRs mediates local and systemic inflammation in a mouse model of primary Sjogren's syndrome","volume":"10","author":"Kiripolsky","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2025.103467_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102608","article-title":"Tissue-specific activation of Myd88-dependent pathways governs disease severity in primary Sjogren's syndrome","volume":"118","author":"Kiripolsky","year":"2021","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2025.103467_bib19","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1246818","article-title":"Current and emerging evidence for toll-like receptor activation in Sjogren's syndrome","volume":"2018","author":"Kiripolsky","year":"2018","journal-title":"J Immunol Res"},{"issue":"3","key":"10.1016\/j.jaut.2025.103467_bib20","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1365-2249.2006.03311.x","article-title":"Expression of functional Toll-like receptors by salivary gland epithelial cells: increased mRNA expression in cells derived from patients with primary Sj\u00f6gren's syndrome","volume":"147","author":"Spachidou","year":"2007","journal-title":"Clin. Exp. Immunol."},{"issue":"4","key":"10.1016\/j.jaut.2025.103467_bib21","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/annrheumdis-2016-209589","article-title":"Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sjogren's syndrome","volume":"76","author":"Maria","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.jaut.2025.103467_bib22","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/ng.472","article-title":"Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus","volume":"41","author":"Han","year":"2009","journal-title":"Nat. Genet."},{"issue":"8","key":"10.1016\/j.jaut.2025.103467_bib23","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1177\/09612033231180695","article-title":"Systemic lupus erythematosus and toll-like receptor 9 polymorphisms: a meta-analysis of genetic association studies","volume":"32","author":"Lee","year":"2023","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.jaut.2025.103467_bib24","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96795","article-title":"Impaired TLR9 responses in B cells from patients with systemic lupus erythematosus","volume":"3","author":"Gies","year":"2018","journal-title":"JCI Insight"},{"issue":"7909","key":"10.1016\/j.jaut.2025.103467_bib25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41586-022-04642-z","article-title":"TLR7 gain-of-function genetic variation causes human lupus","volume":"605","author":"Brown","year":"2022","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.jaut.2025.103467_bib26","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/art.42416","article-title":"De novo PACSIN1 gene variant found in childhood lupus and a role for PACSIN1\/TRAF4 complex in toll-like receptor 7 activation","volume":"75","author":"Xie","year":"2023","journal-title":"Arthritis Rheumatol."},{"issue":"3","key":"10.1016\/j.jaut.2025.103467_bib27","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.immuni.2006.07.013","article-title":"Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus","volume":"25","author":"Christensen","year":"2006","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.jaut.2025.103467_bib28","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.1038\/s41467-021-25102-8","article-title":"Altered function and differentiation of age-associated B cells contribute to the female bias in lupus mice","volume":"12","author":"Ricker","year":"2021","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.jaut.2025.103467_bib29","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1097\/HJH.0000000000002368","article-title":"Toll-like receptor 7-driven lupus autoimmunity induces hypertension and vascular alterations in mice","volume":"38","author":"Robles-Vera","year":"2020","journal-title":"J. Hypertens."},{"key":"10.1016\/j.jaut.2025.103467_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.914468","article-title":"TLR7 activation accelerates cardiovascular pathology in a mouse model of lupus","volume":"13","author":"Elshikha","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jaut.2025.103467_bib31","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.immuni.2019.12.005","article-title":"Distinct effector B cells induced by unregulated toll-like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus","volume":"52","author":"Jenks","year":"2020","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.jaut.2025.103467_bib32","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41584-020-00544-4","article-title":"Toll-like receptor signalling in B cells during systemic lupus erythematosus","volume":"17","author":"Fillatreau","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"issue":"40","key":"10.1016\/j.jaut.2025.103467_bib33","doi-asserted-by":"crossref","first-page":"16276","DOI":"10.1073\/pnas.1209372109","article-title":"Dual signaling by innate and adaptive immune receptors is required for TLR7-induced B-cell-mediated autoimmunity","volume":"109","author":"Walsh","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.jaut.2025.103467_bib34","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.4049\/jimmunol.1401720","article-title":"B cell-intrinsic TLR7 signaling is essential for the development of spontaneous germinal centers","volume":"193","author":"Soni","year":"2014","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.jaut.2025.103467_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173471","article-title":"Toll-like receptor 9 suppresses lupus disease in Fas-sufficient MRL Mice","volume":"12","author":"Nickerson","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jaut.2025.103467_bib36","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.4049\/jimmunol.1501943","article-title":"TLR9 deficiency leads to accelerated renal disease and myeloid lineage abnormalities in pristane-induced murine lupus","volume":"197","author":"Bossaller","year":"2016","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.jaut.2025.103467_bib37","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.4049\/jimmunol.177.2.1349","article-title":"Role of TLR9 in anti-nucleosome and anti-DNA antibody production in lpr mutation-induced murine lupus","volume":"177","author":"Lartigue","year":"2006","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.jaut.2025.103467_bib38","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.4049\/jimmunol.1402425","article-title":"Cell-intrinsic expression of TLR9 in autoreactive B cells constrains BCR\/TLR7-dependent responses","volume":"194","author":"Nundel","year":"2015","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.jaut.2025.103467_bib39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.smim.2006.12.005","article-title":"Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors","volume":"19","author":"Christensen","year":"2007","journal-title":"Semin. Immunol."},{"issue":"10","key":"10.1016\/j.jaut.2025.103467_bib40","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1002\/art.40535","article-title":"Toll-like receptor 9 deficiency breaks tolerance to RNA-associated antigens and up-regulates toll-like receptor 7 protein in Sle1 mice","volume":"70","author":"Celhar","year":"2018","journal-title":"Arthritis Rheumatol."},{"issue":"6","key":"10.1016\/j.jaut.2025.103467_bib41","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1172\/JCI132328","article-title":"B cell-intrinsic TLR9 expression is protective in murine lupus","volume":"130","author":"Tilstra","year":"2020","journal-title":"J. Clin. Investig."},{"issue":"10","key":"10.1016\/j.jaut.2025.103467_bib42","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.4049\/jimmunol.1400098","article-title":"Opposing impact of B cell-intrinsic TLR7 and TLR9 signals on autoantibody repertoire and systemic inflammation","volume":"192","author":"Jackson","year":"2014","journal-title":"J. Immunol."},{"issue":"16","key":"10.1016\/j.jaut.2025.103467_bib43","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.172219","article-title":"B cell-intrinsic TLR7 expression drives severe lupus in TLR9-deficient mice","volume":"8","author":"Cosgrove","year":"2023","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.jaut.2025.103467_bib44","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/cei.13242","article-title":"Activation of Toll-like receptor 7 signaling in labial salivary glands of primary Sjogren's syndrome patients","volume":"196","author":"Shimizu","year":"2019","journal-title":"Clin. Exp. Immunol."},{"issue":"6","key":"10.1016\/j.jaut.2025.103467_bib45","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.tripleo.2010.01.006","article-title":"Expression of Toll-like receptors 7, 8, and 9 in primary Sj\u00f6gren's syndrome","volume":"109","author":"Zheng","year":"2010","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"issue":"1","key":"10.1016\/j.jaut.2025.103467_bib46","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s42358-024-00360-4","article-title":"Elevated expression of Toll-like receptor 7 and its correlation with clinical features in patients with primary Sjogren's syndrome","volume":"64","author":"Yang","year":"2024","journal-title":"Adv Rheumatol"},{"issue":"3","key":"10.1016\/j.jaut.2025.103467_bib47","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/sji.12520","article-title":"Expression of Toll-like receptors in peripheral blood mononuclear cells of patients with primary Sjogren\u2019s syndrome","volume":"85","author":"Karlsen","year":"2017","journal-title":"Scand. J. Immunol."},{"issue":"6","key":"10.1016\/j.jaut.2025.103467_bib48","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/sji.12368","article-title":"TLR-7 and -9 stimulation of peripheral blood B cells indicate altered TLR signalling in primary Sjogren's syndrome patients by increased secretion of Cytokines","volume":"82","author":"Karlsen","year":"2015","journal-title":"Scand. J. Immunol."},{"issue":"10","key":"10.1016\/j.jaut.2025.103467_bib49","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1136\/annrheumdis-2016-210509","article-title":"H1N1 vaccination in Sjogren's syndrome triggers polyclonal B cell activation and promotes autoantibody production","volume":"76","author":"Brauner","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2025.103467_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1034336","article-title":"TLR7 agonism accelerates disease in a mouse model of primary Sjogren's syndrome and drives expansion of T-bet(+) B cells","volume":"13","author":"Punnanitinont","year":"2022","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.jaut.2025.103467_bib51","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/jleuko\/qiad135","article-title":"TLR7 activation of age-associated B cells mediates disease in a mouse model of primary Sjogren's disease","volume":"115","author":"Punnanitinont","year":"2024","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jaut.2025.103467_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2024.1434269","article-title":"Tlr7 drives sex- and tissue-dependent effects in Sjogren's disease","volume":"12","author":"Punnanitinont","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.jaut.2025.103467_bib53","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/1529-0131(199801)41:1<150::AID-ART18>3.0.CO;2-T","article-title":"A novel NOD-derived murine model of primary Sjogren's syndrome","volume":"41","author":"Robinson","year":"1998","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2025.103467_bib54","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.clim.2017.04.009","article-title":"Systemic manifestations of primary Sjogren's syndrome in the NOD.B10Sn-H2b\/J mouse model","volume":"183","author":"Kiripolsky","year":"2017","journal-title":"Clin Immunol"},{"issue":"6","key":"10.1016\/j.jaut.2025.103467_bib55","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/acr.21610","article-title":"Primary Sjogren's syndrome as a systemic disease: a study of participants enrolled in an international Sjogren's syndrome registry","volume":"64","author":"Malladi","year":"2012","journal-title":"Arthritis Care Res."},{"issue":"2","key":"10.1016\/j.jaut.2025.103467_bib56","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaut.2005.11.004","article-title":"Sj\u00f6gren's syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease","volume":"26","author":"Gao","year":"2006","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.jaut.2025.103467_bib57","doi-asserted-by":"crossref","first-page":"382","DOI":"10.4049\/jimmunol.179.1.382","article-title":"IL-4-STAT6 signal transduction-dependent induction of the clinical phase of Sj\u00f6gren's syndrome-like disease of the nonobese diabetic mouse","volume":"179","author":"Nguyen","year":"2007","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.jaut.2025.103467_bib58","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1189\/jlb.2A0715-297R","article-title":"Analysis of IgM antibody production and repertoire in a mouse model of Sjogren's syndrome","volume":"99","author":"Kramer","year":"2016","journal-title":"J. Leukoc. Biol."},{"issue":"9","key":"10.1016\/j.jaut.2025.103467_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2024.103608","article-title":"Reflecting on a decade of the international consensus on ANA patterns (ICAP): accomplishments and challenges from the perspective of the 7th ICAP workshop","volume":"23","author":"Andrade","year":"2024","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2025.103467_bib60","series-title":"_R: A Language and Environment for Statistical Computing_","year":"2024"},{"key":"10.1016\/j.jaut.2025.103467_bib61","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. Roy. Stat. Soc. B"},{"issue":"7","key":"10.1016\/j.jaut.2025.103467_bib62","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/art.42844","article-title":"Amplified type I interferon response in Sjogren's disease via ectopic toll-like receptor 7 expression in salivary gland epithelial cells induced by lysosome-associated membrane protein 3","volume":"76","author":"Nakamura","year":"2024","journal-title":"Arthritis Rheumatol."},{"issue":"24","key":"10.1016\/j.jaut.2025.103467_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21249478","article-title":"Toll-like receptor 7 is required for lacrimal gland autoimmunity and type 1 diabetes development in male nonobese diabetic mice","volume":"21","author":"Debreceni","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jaut.2025.103467_bib64","article-title":"TLR7 signaling drives the development of Sjogren's syndrome","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.jaut.2025.103467_bib65","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1073\/pnas.1314121111","article-title":"TLR8 on dendritic cells and TLR9 on B cells restrain TLR7-mediated spontaneous autoimmunity in C57BL\/6 mice","volume":"111","author":"Desnues","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.jaut.2025.103467_bib66","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.rdc.2016.03.002","article-title":"Autoantibodies in Sjogren's syndrome","volume":"42","author":"Fayyaz","year":"2016","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.jaut.2025.103467_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.980400","article-title":"Nucleic acid-sensing toll-like receptors: important players in Sjogren's syndrome","volume":"13","author":"Alexopoulou","year":"2022","journal-title":"Front. Immunol."},{"issue":"6644","key":"10.1016\/j.jaut.2025.103467_bib68","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1126\/science.adg6427","article-title":"Innate virus-sensing pathways in B cell systemic autoimmunity","volume":"380","author":"Vinuesa","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.jaut.2025.103467_bib69","doi-asserted-by":"crossref","DOI":"10.1369\/0022155420930303","article-title":"Communications via the small leucine-rich proteoglycans: molecular specificity in inflammation and autoimmune diseases","author":"Zeng-Brouwers","year":"2020","journal-title":"J. Histochem. Cytochem."},{"issue":"36","key":"10.1016\/j.jaut.2025.103467_bib70","doi-asserted-by":"crossref","first-page":"24035","DOI":"10.1074\/jbc.M109.014266","article-title":"Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors","volume":"284","author":"Babelova","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.jaut.2025.103467_bib71","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/JLB.4MIR1018-397RR","article-title":"A STING to inflammation and autoimmunity","volume":"106","author":"Kumar","year":"2019","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.jaut.2025.103467_bib72","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s10787-023-01393-9","article-title":"Rapamycin can alleviate the submandibular gland pathology of Sjogren's syndrome by limiting the activation of cGAS-STING signaling pathway","volume":"32","author":"Zhu","year":"2024","journal-title":"Inflammopharmacology"},{"issue":"10","key":"10.1016\/j.jaut.2025.103467_bib73","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.7150\/ijms.83801","article-title":"Lactate-induced mtDNA accumulation activates cGAS-STING signaling and the inflammatory response in Sjogren's syndrome","volume":"20","author":"Xu","year":"2023","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.jaut.2025.103467_bib74","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jtos.2023.09.012","article-title":"Genomic DNA activates the AIM2 inflammasome and STING pathways to induce inflammation in lacrimal gland myoepithelial cells","volume":"30","author":"Yang","year":"2023","journal-title":"Ocul. Surf."},{"issue":"8","key":"10.1016\/j.jaut.2025.103467_bib75","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1093\/rheumatology\/keac016","article-title":"Hyperresponsive cytosolic DNA-sensing pathway in monocytes from primary Sjogren's syndrome","volume":"61","author":"Huijser","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2025.103467_bib76","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.97069","article-title":"Dysregulated Ca(2+) signaling, fluid secretion, and mitochondrial function in a mouse model of early Sjogren's disease","volume":"13","author":"Huang","year":"2024","journal-title":"eLife"},{"issue":"12","key":"10.1016\/j.jaut.2025.103467_bib77","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21124512","article-title":"Pulmonary involvement in a mouse model of Sjogren's syndrome induced by STING activation","volume":"21","author":"Papinska","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"40","key":"10.1016\/j.jaut.2025.103467_bib78","doi-asserted-by":"crossref","first-page":"16626","DOI":"10.1074\/jbc.M117.790741","article-title":"P2X7 receptor antagonism prevents IL-1beta release from salivary epithelial cells and reduces inflammation in a mouse model of autoimmune exocrinopathy","volume":"292","author":"Khalafalla","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.jaut.2025.103467_bib79","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/joim.12631","article-title":"The P2X7 receptor-NLRP3 inflammasome complex predicts the development of non-Hodgkin's lymphoma in Sjogren's syndrome: a prospective, observational, single-centre study","volume":"282","author":"Baldini","year":"2017","journal-title":"J. Intern. Med."},{"issue":"2","key":"10.1016\/j.jaut.2025.103467_bib80","doi-asserted-by":"crossref","first-page":"R64","DOI":"10.1186\/ar3780","article-title":"TLR2 ligation induces the production of IL-23\/IL-17 via IL-6, STAT3 and NF-kB pathway in patients with primary Sjogren's syndrome","volume":"14","author":"Kwok","year":"2012","journal-title":"Arthritis Res. Ther."},{"issue":"8","key":"10.1016\/j.jaut.2025.103467_bib81","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1177\/0022034518760855","article-title":"Activation of stimulator of interferon genes (STING) and Sjogren syndrome","volume":"97","author":"Papinska","year":"2018","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.jaut.2025.103467_bib82","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.46997","article-title":"TLR induces reorganization of the IgM-BCR complex regulating murine B-1 cell responses to infections","volume":"8","author":"Savage","year":"2019","journal-title":"eLife"},{"issue":"5","key":"10.1016\/j.jaut.2025.103467_bib83","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/JLB.3RI0519-161R","article-title":"Secreted IgM: new tricks for an old molecule","volume":"106","author":"Blandino","year":"2019","journal-title":"J. Leukoc. Biol."},{"issue":"1\u20133","key":"10.1016\/j.jaut.2025.103467_bib84","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12026-015-8708-3","article-title":"The role of B-1 cells in inflammation","volume":"63","author":"Aziz","year":"2015","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jaut.2025.103467_bib85","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.47015","article-title":"B cell receptor and Toll-like receptor signaling coordinate to control distinct B-1 responses to both self and the microbiota","volume":"8","author":"Kreuk","year":"2019","journal-title":"eLife"},{"issue":"13","key":"10.1016\/j.jaut.2025.103467_bib86","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12134423","article-title":"The toll-like receptor 7-mediated Ro52 antigen-presenting pathway in the salivary gland epithelial cells of Sjogren's syndrome","volume":"12","author":"Nishihata","year":"2023","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.jaut.2025.103467_bib87","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/cei.13077","article-title":"Activation of plasmacytoid dendritic cells by apoptotic particles - mechanism for the loss of immunological tolerance in Sjogren's syndrome","volume":"191","author":"Ainola","year":"2018","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"10.1016\/j.jaut.2025.103467_bib88","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yexcr.2018.12.027","article-title":"Toll-like receptor 9 signaling promotes autophagy and apoptosis via divergent functions of the p38\/JNK pathway in human salivary gland cells","volume":"375","author":"Fu","year":"2019","journal-title":"Exp. Cell Res."},{"issue":"8","key":"10.1016\/j.jaut.2025.103467_bib89","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1073\/pnas.0510837103","article-title":"Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sj\u00f6gren's syndrome","volume":"103","author":"Gottenberg","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.jaut.2025.103467_bib90","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/ard-2022-222728","article-title":"Deciphering the role of cDC2s in Sjogren's syndrome: transcriptomic profile links altered antigen processes with IFN signature and autoimmunity","volume":"82","author":"Lopes","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2025.103467_bib91","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.854183","article-title":"Aberrant signaling of immune cells in Sjogren's syndrome patient subgroups upon interferon stimulation","volume":"13","author":"Sarkar","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jaut.2025.103467_bib92","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-15537-4","article-title":"Alterations in corneal epithelial dendritic cell in Sjogren's syndrome dry eye and clinical correlations","volume":"12","author":"Hao","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2025.103467_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116885","article-title":"Artesunate alleviates Sjogren's Syndrome by inhibiting the interferon-alpha signaling in plasmacytoid dendritic cells via TLR-MyD88-IRF7","volume":"177","author":"Zhou","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.jaut.2025.103467_bib94","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1167\/iovs.66.1.35","article-title":"S100A8\/A9 promotes dendritic cell-mediated Th17 cell response in Sjogren's dry eye disease by regulating the Acod1\/STAT3 pathway","volume":"66","author":"Wei","year":"2025","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.jaut.2025.103467_bib95","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1038\/s41467-021-23472-7","article-title":"A new molecular classification to drive precision treatment strategies in primary Sjogren's syndrome","volume":"12","author":"Soret","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jaut.2025.103467_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2024.110241","article-title":"Consensus gene modules strategy identifies candidate blood-based biomarkers for primary Sjogren's disease","volume":"264","author":"Boudjeniba","year":"2024","journal-title":"Clin Immunol"},{"issue":"4","key":"10.1016\/j.jaut.2025.103467_bib97","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/rheumatology\/kez335","article-title":"Unique Sjogren's syndrome patient subsets defined by molecular features","volume":"59","author":"James","year":"2020","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.jaut.2025.103467_bib98","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/odi.14506","article-title":"Association of G protein-coupled receptor 78 with salivary dysfunction in male Sjogren's patients","volume":"30","author":"Tanaka","year":"2024","journal-title":"Oral Dis."},{"issue":"10","key":"10.1016\/j.jaut.2025.103467_bib99","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1111\/1756-185X.13940","article-title":"Male patients with primary Sjogren's syndrome: a distinct clinical subgroup?","volume":"23","author":"Park","year":"2020","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.jaut.2025.103467_bib100","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13293-017-0137-7","article-title":"Difference in clinical presentation between women and men in incident primary Sjogren's syndrome","volume":"8","author":"Ramirez Sepulveda","year":"2017","journal-title":"Biol. Sex Differ."},{"issue":"1","key":"10.1016\/j.jaut.2025.103467_bib101","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13293-017-0146-6","article-title":"Long-term follow-up in primary Sjogren's syndrome reveals differences in clinical presentation between female and male patients","volume":"8","author":"Ramirez Sepulveda","year":"2017","journal-title":"Biol. Sex Differ."},{"issue":"1","key":"10.1016\/j.jaut.2025.103467_bib102","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13293-017-0153-7","article-title":"Sex influences eQTL effects of SLE and Sjogren's syndrome-associated genetic polymorphisms","volume":"8","author":"Linden","year":"2017","journal-title":"Biol. Sex Differ."},{"key":"10.1016\/j.jaut.2025.103467_bib103","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.958670","article-title":"Sex differences in comorbidities associated with Sjogren's disease","volume":"9","author":"Bruno","year":"2022","journal-title":"Front. Med."},{"issue":"6","key":"10.1016\/j.jaut.2025.103467_bib104","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1007\/s10067-024-06955-y","article-title":"Male patients with primary Sjogren's syndrome have unique clinical manifestations and circulating lymphocyte profiles","volume":"43","author":"Liu","year":"2024","journal-title":"Clin. Rheumatol."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089684112500112X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089684112500112X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T03:58:26Z","timestamp":1779681506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089684112500112X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":104,"alternative-id":["S089684112500112X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2025.103467","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tlr9 expression protects against Tlr7-dependent exocrine gland and systemic disease manifestations in primary Sj\u00f6gren's disease in a sex-biased manner","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2025.103467","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103467"}}